Covered recipient · General Payments record
DANIELLE N ZACHARY
Physician Assistants & Advanced Practice Nursing Providers Clinical Nurse Specialist
General Payments · PY2021–2024
$1,623.60
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $430.57 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $152.27 | 8 |
| Lilly USA, LLC | $49.16 | 3 |
| Acerta Pharma LLC | $41.37 | 3 |
| Teva Pharmaceuticals USA, Inc. | $40.66 | 2 |
| PFIZER INC. | $32.08 | 2 |
| Antares Pharma, Inc. | $19.71 | 1 |
| Ascensia Diabetes Care US Inc. | $19.69 | 1 |
| CeQur Corporation | $16.57 | 1 |
| IBSA Pharma Inc. | $16.16 | 1 |
| Novo Nordisk AS | $15.71 | 1 |
| Amgen Inc. | $14.19 | 1 |
| Organon LLC | $13.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.54 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455760 | CMS |
| ABBVIE INC. | $15.59 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455762 | CMS |
| ABBVIE INC. | $17.18 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455764 | CMS |
| ABBVIE INC. | $31.38 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455766 | CMS |
| ABBVIE INC. | $29.52 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455768 | CMS |
| ABBVIE INC. | $10.39 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455770 | CMS |
| ABBVIE INC. | $13.66 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455772 | CMS |
| ABBVIE INC. | $16.01 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108455774 | CMS |
| Amgen Inc. | $14.19 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117724892 | CMS |
| Antares Pharma, Inc. | $19.71 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146528617 | CMS |
| Ascensia Diabetes Care Us Inc. | $19.69 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089089994 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.93 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105817641 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104533030 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.00 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104382551 | CMS |
| CeQur Corporation | $16.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099649245 | CMS |
| IBSA Pharma Inc. | $16.16 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142986685 | CMS |
| Lilly USA, LLC | $16.40 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135601135 | CMS |
| Lilly USA, LLC | $17.75 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135564202 | CMS |
| Lilly USA, LLC | $15.01 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135601905 | CMS |
| Novo Nordisk Inc | $15.71 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100383511 | CMS |
| Organon Llc | $13.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136268508 | CMS |
| PFIZER INC. | $15.85 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131920743 | CMS |
| PFIZER INC. | $16.23 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131929342 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151485101 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.16 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151485169 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.